UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the CJS Securities 25th Annual Summer Conference

UFP Technologies, Inc. (Nasdaq: UFPT) is set to participate in the CJS Securities 25th Annual Summer Conference on July 10, 2025. Mitchell Rock, the company’s President, and Ron Lataille, Senior Vice President and CFO, will present and engage in one-on-one meetings with investors, highlighting the company’s strategic initiatives and financial outlook.

Founded as a contract development and manufacturing organization (CDMO), UFP Technologies specializes in the design and production of single-use, polymer-based medical devices and components. The company plays a crucial role in the healthcare sector by partnering with leading medical device manufacturers to enhance patient outcomes while reducing costs. This collaboration allows healthcare providers to focus on delivering quality care as UFP handles device innovation and manufacturing processes.

UFP’s unique approach combines a differentiated materials platform with extensive engineering capabilities, positioning the company as a reliable partner in highly regulated markets, including robotic-assisted surgery, safe patient handling, infection prevention, interventional devices, orthopedics, and wound care. The company’s focus on low-cost manufacturing helps its partners to minimize expenses while maintaining high-quality standards and compliance with industry regulations.

As UFP Technologies continues to expand its footprint in the medical device sector, its participation in the CJS Securities conference illustrates its commitment to fostering relationships with investors and sharing insights into its growth trajectory. The company’s strategic focus on partnerships and innovation within high-barrier markets can serve as a solid foundation for future growth and shareholder value.

For further inquiries, interested parties can reach Ron Lataille, CFO of UFP Technologies, directly at 978-234-0926 or via email at rlataille@ufpt.com.

As UFP Technologies, Inc. (Nasdaq: UFPT) prepares for its participation in the CJS Securities 25th Annual Summer Conference, investors should take a closer look at the company's fundamentals and market positioning. UFP Technologies operates within a robust niche in the healthcare sector as a contract development and manufacturing organization (CDMO), particularly in polymer-based medical devices. This specialization aligns with the ongoing trend of outsourcing among medical device companies, presenting a significant growth opportunity.

UFP's differentiated materials and engineering expertise establish it as a trusted partner in high-barrier, regulated markets such as robotic-assisted surgery, infection prevention, and orthopedics. These markets are characterized by stringent regulatory environments and require a high level of innovation and reliability in product development. Furthermore, the increasing adoption of single-use devices due to safety and efficacy considerations bolsters demand for UFP's offerings.

From a financial perspective, the company has demonstrated strong operational performance, evident from its steady revenue growth and healthy margins. Investors should monitor UFP's ability to maintain this trajectory and expand its market share in the face of increasing competition. The 1x1 meetings hosted at the conference present an invaluable opportunity for investors to glean insights from UFP’s leadership on strategic initiatives, recent innovations, and financial health.

It is advisable for stakeholders to keep an eye on the company's pipeline of new product developments and partnerships, which could further strengthen its market position. Given UFP's strategic focus and the positive industry outlook, the company appears well-equipped to capitalize on expanding market opportunities. Investors should consider whether the current valuation reflects the underlying growth potential and their risk tolerance in this evolving landscape.